Researchers have developed a machine learning model called DreaMS, which significantly accelerates the analysis of previously unknown molecules. The study is published in Nature Biotechnology.

Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with newly ...

The Supreme Court (SC) reminded employers that once their job offers are accepted by the workers, an employer-employee ...

Congress has not been able to reauthorize environmental statutes for years, with some (most) needing significant attention. EPA relies on 1990 Clean Air Act amendments to sort out air pollution issues ...

BRANY announces the launch of Protocol Builder® 2.0, an advanced cloud-based tool for protocol writing, now enhanced with AI ...

Russia proposes second round of direct talks with Ukraine in Istanbul Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and ...

The first-of-its-kind event felt like a collision of meme culture, bro podcast masculinity, and the ongoing effort to biotech ...

Axolotl limbs regenerate functional body parts in just weeks, relying on cells that retain positional memory. The Hand2 gene ...

Immunocore's positive revenue growth highlights its competitive position in the biotechnology sector ... information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, ...

“Tune is delighted to receive this partnership award with Novotech," said Dr. Heidi Zhang, Chief Development Officer at Tune Therapeutics. "Together, we have achieved a global first in bringing this ...

The company is reimagining the fragmented reality of molecular research by building the world's largest RNA sequencing ...

CITY 100, the inaugural smartphone in its brand-new CITY Series. itel CITY 100 redefines expectations for budget smartphones by integrating strong ...